Catecholamine biosynthesis and physiological regulation in neuroendocrine cells

Acta Physiologica Scandinavica

Volumn 168, Issue 1, 2000, Pages 1-17

  Flatmark, Torgier ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Adrenaline; Biosynthesis; Catecholamine; Dopamine; Human genetics; L DOPA; Noradrenaline; Post translational regulation; Tetrahydrobiopterin; Transcriptional regulation; Transgenic animals

Indexed keywords

ADRENALIN; CATECHOLAMINE; CATECHOLAMINE RECEPTOR; DOPAMINE; ENZYME; NORADRENALIN; RECOMBINANT PROTEIN; TETRAHYDROBIOPTERIN; TYROSINE 3 MONOOXYGENASE;

CATECHOLAMINE SYNTHESIS; DEGRADATION; GENETIC TRANSCRIPTION; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL;

ANIMALS; CATECHOLAMINES; CHEMISTRY; ENZYMES; HUMANS; METABOLIC DISEASES; MUTATION; NEUROSECRETORY SYSTEMS;

EID: 0034049254     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.2000.00596.x     Document Type: Review

References (143)

1. Abudu, N., Banjaw, M.Y. & Ljones, T. 1998. Kinetic studies on the activation of dopamine beta-monooxygenase by copper and vanadium ions. Eur J Biochem 257, 622-629.
2. Almås, B., Le Bourdelles, B., Flatmark, T., Mallet, J. & Haavik, J. 1992. Regulation of recombinant human tyrosine hydroxylase isozymes by catecholamine binding and phosphorylation. Structure/activity studies and mechanistic implications. Eur J Biochem 209, 249-255.
3. Almås, B., Haavik, J. & Flatmark, T. 1996. Characterization of a novel pterin intermediate formed in the catalytic cycle of tyrosine hydroxylase. Biochem J 319, 947-951.
4. Anastasiadis, P.Z., Bezin, L., Gordon, L.J., Imerman, B., Blitz, J. & Levine, R.A. 1998. Vasoactive intestinal peptide induces both tyrosine hydroxylase activity and tetrahydrobiopterin biosynthesis in PC12 cells. Neuroscience 86, 179-189.
5. Andersson, K.K., Cox, D.D., Que, L. Jr, Flatmark, T. & Haavik, J. 1988. Resonance Raman studies on the blue-green-colored bovine adrenal tyrosine 3-monooxygenase (tyrosine hydroxylase). Evidence that the feedback inhibitors adrenaline and noradrenaline are coordinated to iron. J Biol Chem 263, 18621-18626.
6. Axelrod, J. 1971. Noradrenaline: fate and control of its biosynthesis. Science 173, 598-606.
7. Baetge, E.E., Kaplan, B.B., Reis, D.J. & Joh, T.H. 1981. Translation of tyrosine hydroxylase from poly(A)-mRNA in pheochromocytoma cells is enhanced by dexamethasone. Proc Natl Acad Sci USA 78, 1269-1273.
8. Baruchin, A., Weisberg, E.P., Miner, L.L. et al. 1990. Effects of cold exposure on rat adrenal tyrosine hydroxylase: an analysis of RNA, protein, enzyme activity, and cofactor levels. J Neurochem 54, 1769-1775.
9. Beitner-Johnson, D. & Millhorn, D.E. 1998. Hypoxia induces phosphorylation of the cyclic AMP response element-binding protein by a novel signaling mechanism. J Biol Chem 273, 19834-19839.
10. Betito, K., Mitchell, J.B., Bhatnagar, S., Boksa, P. & Meaney, M.J. 1994. Regulation of the adrenomedullary catecholaminergic system after mild, acute stress. Am J Physiol 267, R212-R220.
11. Bjerrum, O.J., Helle, K.B. & Bock, E. 1979. Immunochemically identical hydrophilic and amphiphilic forms of the bovine adrenomedullary dopamine beta-hydroxylase. Biochem J 181, 231-237.
12. Blaschko, H. 1939. The specific action of L-DOPA decarboxylase. J Physiol (Lond) 96, 50P-51P.
13. Bloom, F.E. & Hoffer, B.J. 1973. Norepinephrine as a central synaptic transmitter. In: E. Usdin & S.L. Snyder (eds) Frontiers in Catecholamine Research, pp. 637-642. Pergamon, New York.
14. Brown, G.L. & Gillespie, J.S. 1957. The output of sympathetic transmitter from the spleen of the cat. J Physiol (Lond) 138, 81-102.
15. Cadd, G.G., Hoyle, G.W., Quaife, C.J. et al. 1992. Alteration of neurotransmitter phenotype in noradrenergic neurons of transgenic mice. Mol Endocrinol 6, 1951-1960.
16. Caine, J.M., Macreadie, I.G., Grunewald, G.L. & McLeish, M.J. 1996. Recombinant human phenylethanolamine N-methyltransferase: overproduction in Eschericia coli, purfi-cation, and characterization. Protein Expr Purif 8, 160-166.
17. Campbell, D.G., Hardie, D.G. & Vulliet, P.R. 1986. Identification of four phosphorylation sites in the N-terminal region of tyrosine hydroxylase. J Biol Chem 261, 10489-10492.
18. Cannon, B., Nedergaard, J., Lundberg, J.M., Hökfelt, T., Terenius, L. & Goldstein, M. 1986. 'Neuropeptide tyrosine' (NPY) is co-stored with noradrenline in vascular but not in parenchymal sympathetic nerves of brown adipose tissue. Exp Cell Res 164, 546-550.
19. Cannon, B., Jacobsson, A., Rehnmark, S. & Nedergaard, J. 1996. Signal transduction in brown adipose tissue recruitment: noradrenaline and beyond. Int J Obes Relat Metab Disord 20 (Suppl 3), S36-S42.
20. Carlsson, A. 1959. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev 11, 490-493.
21. Chalazonitis, A., Rice, P.J. & Zigmond, R.E. 1980. Increased ganglionic tyrosine hydroxylase and dopamine-beta-hydroxylase activities following preganglionic nerve stimulation: role of nicotine receptors. J Pharmacol Exp Ther 213, 139-143.
22. Christensen, N.J. 1991. The biochemical assesment of sympathoadrenal activity in man. Clin Auton Res 1, 167-172.
23. Cumming, P., Kuwabara, H., Ase, A. & Gjedde, A. 1995. Regulation of DOPA decarboxylase activity in brain of living rat. J Neurochem 65, 1381-1390.
24. Cumming, P. & Gjedde, A. 1998. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synanpse 29, 37-61.
25. Czyzyk-Krzeska, M.F., Paulding, W.R., Beresh, J.E. & Kroll, S.L. 1997. Post-transcritional regulation of tyrosine hydroxylase gene expression by oxygen in PC12 cells. Kidney Int 51, 585-590.
26. Dassesse, D., Hemmens, B., Cuverlier, L. & Resibois, A. 1997. GTP-cyclohydrolase-I like immunoreactivity in rat brain. Brain Res 777, 187-201.
27. Davis, J.N. 1975. Adaptation of brain monoamine synthesis to hypoxia in the rat. J Appl Physiol 39, 215-220.
28. Diaz Borges, J.M., Urbina, M. & Drujan, B.D. 1978. Some properties of phenylethanolamine-N-methyltransferase of rat brain. Neurochem Res 3, 15-26.
29. Eidelberg, D. 1992. Positron emission tomography studies in parkinsonism. Neurol Clin 10, 421-433.
30. Elliott, T.R. 1904. On the action of adrenalin. J Physiol (Lond) 31, 20-21.
31. Elliott, T.R. 1905. The action of adrenalin. J Physiol (Lond) 32, 401-467.
32. Erlandsen, H., Flatmark, T., Stevens, R.C. & Hough, E. 1998. Crystallographic analysis of the human phenylalanine hydroxylase catalytic domain with bound catechol inhibitors at 2.0 A resolution. Biochemistry 37, 15638-15646.
33. von Euler, U.S. 1946. A specific sympathomimetic ergone in adrenergic nerve fibres (sympathin) and its relation to adrenaline and noradrenaline. Acta Physiol Scand 12, 73-97.
34. von Euler, U.S. & Hillarp, N.A. 1957. Evidence for the presence of noradrenaline in submicroscopic structures of adrenergic axons. Nature 177, 44-45.
35. von Euler, U.S. 1971. Adrenergic neurotransmitter functions. Science 173, 202-206.
36. Evinger, M.J. 1998. Determinants of Phenylethanolamine-N-methyltransferase expression. Adv Pharmacol 42, 73-76.
37. Falch, B., Hillarp, N.-A., Thieme, G. & Torp, A. 1962. Fluorescence of catecholamines and related compounds condensed with formaldehyde. J Histochem Cytochem 10, 348-354.
38. Faucon Biguet, N., Vyas, S. & Mallet, J. 1991. In vitro and in vivo regulation of the expression of the tyrosine hydroxylase gene. J Physiol (Paris) 85, 105-109.
39. 561 of the bovine adrenal chromaffin granules. A high potential b-type cytochrome. Biochim Biophys Acta 253, 487-491.
40. Flatmark, T. & Pedersen, J.I. 1975. Brown adipose tissue mitochondria. Biochim Biophys Acta 416, 53-103.
41. Flatmark, T. & Knappskog, P.M. 1998. Mutations in the genes of the catecholamine biosynthetic enzymes and human diseases. In: T. Kanno, Y. Nakazato & K. Kumakura (eds) The Adrenal Chromaffin Cell, pp. 233-242. Hokkaido University Press, Sapporo.
42. Flatmark, T. & Stevens, R.C. 1999a. Structural insight into the aromatic amino acid hydroxylases and their disease related mutant forms. Chem Rev 99, 2137-2160.
43. Flatmark, T., Almås, B., Knappskog, P.M. et al. 1999b. Tyrosine hydroxylase binds tetrahydrobiopterin with negative cooperativity as studied by kinetic analyses and surface plasmon resonance. Eur J Biochem 262, 840-849.
44. Fregly, M.J., Rossi, F., Sun, Z. et al. 1994. Effect of chronic treatment with prazosin and L-arginine on the elevation of blond pressure during cold exposure. Pharmacology 49, 351-362.
45. Friedman, S. & Kaufman, S. 1965. Physical properties, copper content, and the role of the copper in the catalytic activity. J Biol Chem 240, 4763-4773.
46. Fujinaga, M. & Scott, J.C. 1997. Gene expression of catecholamine synthesising enzymes and beta adrenoceptor subtypes during rat embryogenesis. Neurosci Lett 231, 108-112.
47. Fukami, M.H., Haavik, J. & Flatmark, T. 1990. Phenylalanine as substrate for tyrosine hydroxylase in bovine adrenal chromaffin cells. Biochem J 268, 525-528.
48. Gaspar, P., Berger, B., Febvret, A., Vigny, A. & Henry, J.P. 1989. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine beta-hydroxylase. J Comp Neurol 279, 249-271.
49. Goldstein, D.S., Mezey, E., Yamamoto, T., Aneman, A., Friberg, P. & Eisenhofer, G. 1995. Is there a third peripheral catecholaminergic system? Endogenous dopamine as an autocrine/paracrine substance derived from plasma DOPA and inactivated by conjugation. Hypertens Res 18 (Suppl. 1), S93-S99.
50. Goodwill, K.E., Sabatier, C., Marks, C., Raag, R., Fitzpatrick, P.F. & Stevens, R.C. 1997. Crystal structure of tyrosine hydroxylase at 2.3 Ä and its implications for inherited neurodegenerative diseases. Nat Struct Biol 4, 578-585.
51. Goodwill, K.E., Sabatier, C. & Stevens, R.C. 1998. Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2.3 Ä resolution: self-hydroxylation of Phe300 and the pterin-binding site. Biochemistry 37, 13437-13445.
52. Grunewald, G.L., Ye, Q., Kieffer, L. & Monn, J.A. 1988. Conformational requirements of substrates for activity with phenylethanolamine N-methyltransferase. J Med Chem 31, 169-171.
53. Haavik, J. & Flatmark, T. 1987. Isolation and characterization of tetrahydropterin oxidation products generated in the tyrosine 3-monooxygenase (tyrosine hydroxylase) reaction. Eur J Biochem 168, 21-26.
54. Haavik, J., Schelling, D.L., Campbell, D.G., et al. 1989. Identification of protein phosphatase 2A as the major tyrosine hydroxylase phosphatase in adrenal medulla and corpus striatum: evidence from the effects of okadaic acid. FEBS Lett 251, 36-42.
55. Hagen, P. & Welch, A.D. 1956. The adrenal medulla and the biosynthesis of pressor amines. Recent Progr Hormone Res 12, 27-41.
56. Hartman, R.D., Liaw, J.J., He, J.R. & Barraclough, C.A. 1992. Effects of reserpine on tyrosine hydroxylase mRNA levels in locus coeruleus and medullary A1 and A2 neurons analyzed by in situ hybridization histochemistry and quantitative image analysis methods. Brain Res Mol Brain Res 13, 223-229.
57. Haycock, J.W. & Wakade, A.R. 1992. Activation and multiple-site phosphorylation of tyrosine hydroxylase in perfused rat adrenal glands. J Neurochem 58, 57-64.
58. Hendry, I.A. 1976. Effects of axotomy on the trans-synaptic regulation of enzyme activity in adult rat superior cervical ganglia. Brain Res 107, 105-116.
59. Hertting, G. & Axelrod, J. 1961. Fate of tritiated noradrenaline at the sympathetic nerve-endings. Nature 192, 172-173.
60. Hess, E.J. & Wilson, M.C. 1991. Tottering and leaner mutations perturb transient developmental expression of tyrosine hydroxylase in embryologically distinct Purkinje cells. Neuron 6, 123-132.
61. Hirayama, K. & Kapatos, G. 1998. Nigrostriatal dopamine neurons express low levels of GTP cyclohydrolase I protein. J Neurochem 70, 164-170.
62. Hjemdahl, P. 1993. Plasma catecholamines - analytical challenges and physiological limitations. Baillieres Clin Endocrinol Metab 7, 307-353.
63. Hökfelt, T., Fuxe, K., Goldstein, M. & Johansson, O. 1974. Immono-histochemical evidence for the existence of adrenaline neurons in the rat brain. Brain Res 66, 235-251.
64. Holtz, P. 1950, Über die sympathicomimetische Wirksamkeit von Gehirnextracten. Acta Phys Scand 20, 354-362.
65. Husebye, E.S., Boe, A.S., Rorsman, F. et al. 1999. Inhibition of aromatic L-amino acid decarboxylase activity by human autoantibodies. Submitted.
66. Ichinose, H., Ohye, T., Takahashi, E. et al. 1994. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 8, 236-242.
67. Jiang, W., Uht, R. & Bohn, M.C. 1989. Regulation of phenylethanolamine N-methyltransferase (PNMT) mRNA in the rat adrenal medulla by corticosterone. Int J Dev Neurosci 7, 513-520.
68. Joh, T.H., Son, J.H., Tinti, C., Conti, B., Kim, S.J. & Cho, S. 1998. Unique and cell-type-specific tyrosine hydroxylase gene expression. Advan Pharmacol 42, 33-36.
69. Kaler, S.G., Holmes, C.S. & Goldstein, D.S. 1998. Dopamine β-hydroxylase deficiency associated with mutations in a copper transporter gene. Advan Pharmacol 42, 66-68.
70. Kaufman, S. & Kaufman, E.E. 1985. Tyrosine hydroxylase. In: R.L. Blakley & S.J. Benkovic (eds) Folates and Pterins. Chemistry and Biochemistry of Pterins, pp. 251-352. John Wiley, New York.
71. Kaufman, S., Pollock, R.J., Summer, G.K., Das, A.K. & Hajra, A.K. 1990. Dependence of an alkyl glycol-ether monooxygenase activity upon tetrahydropterins. Biochim Biophys Acta 1040, 19-27.
72. Kelner, K.L. & Pollard, H.B. 1985. Glucocorticoid receptors and regulation of phenylethanolamine-N-methyltransferase activity in cultured chromaffin cells. J Neurosci 5, 2161-2168.
73. Kennedy, B., Elayan, H. & Ziegler, M.G. 1990. Lung epinephrine synthesis. Am J Physiol 258, L227-L231.
74. Knappskog, M., Flatmark, T., Mallet, J., Lüdecke, B. & Bartholomé, K. 1995. Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Gen 4, 1209-1212.
75. Kobayashi, K., Morita, S., Sawada, H. et al. 1995. Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J Biol Chem 270, 27235-27243.
76. Köster, S., Thöny, B., Macheroux, P. et al. 1995. Human pterin-4a-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor-1 alpha: Characterization and kinetic analysis of wild-type and mutant enzymes. Eur J Biochem 231, 414-423.
77. Kuczenski, R.T. & Mandell, A.J. 1972. Regulatory properties of soluble and particulate rat brain tyrosine hydroxylase. J Biol Chem 247, 3114-3122.
78. Kuhn, D.M., Arthur, R., Yoon, H. & Sankaran, K. 1990. Tyrosine hydroxylase in secretory granules from bovine adrenal medulla. Evidence for an integral membrane form. J Biol Chem 265, 5780-5786.
79. Kumer, S.C. & Vrana, K.E. 1996. Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67, 443-462.
80. Kvetnansky, R., Weise, V.K. & Kopin, I.J. 1970. Elevation of adrenal tyrosine hydroxylase and phenylethanolamine-N-methyl transferase by repeated immobilization of rats. Endocrinology 87, 744-749.
81. Lazaroff, M., Patankar, S., Yoon, S.O. & Chikaraishi, D.M. 1995. The cyclic AMP response element directs tyrosine hydroxylase expression in catecholaminergic central and peripheral nervous system cell lines from transgenic mice. J Biol Chem 270, 21579-21589.
82. Lazaroff, M., Qi, Y. & Chikaraishi, D.M. 1998. Differentiation of a catecholaminergic CNS cell line modifies tyrosine hydroxylase transcriptional regulation. J Neurochem 71, 51-59.
83. Lazarus, R.A., Benkovic, S.J. & Kaufman, S. 1983. Phenylalanine hydroxylase stimulator protein is a 4a-carbinolamine dehydratase. J Biol Chem 258, 10960-10962.
84. Le Bourdelles, B., Horellou, P., Le Caer, J.P. et al. 1991. Phosphorylation of human recombinant tyrosine hydroxylase isoforms 1 and 2: an additional phosphorylated residue in isoform 2, generated through alternative splicing. J Biol Chem 266, 17124-17130.
85. Lentz, S.I. & Kapatos, G. 1996. Tetrahydrobiopterin biosynthesis in the rat brain: heterogeneity of GTP cyclohydrolase I mRNA expression in monoamine-containing neurons. Neurochem Int 28, 569-582.
86. Lewis, E.J., Harrington, C.A. & Chikaraishi, D.M. 1987. Transcriptional regulation of the tyrosine hydroxylase gene by glucocorticoid and cyclic AMP. Proc Natl Acad Sci USA 84, 3550-3554.
87. Lin, C.S. & Klingenberg, M. 1980. Isolation of the uncoupling protein from brown adipose tissue mitochondria. FEBS Lett 113, 299-303.
88. Liu, J., Merlie, J.P., Todd, R.D. & O'Malley, K.L. 1997. Identification of cell type-specific promoter elements associated with the rat tyrosine hydroxylase gene using transgenic founder analysis. Brain Res Mol Brain Res 50, 33-42.
89. Loewi, O. 1921. Über humorale Übertragbartkeit der Herzenvenwirkung. Pflügers Arch 189, 239-242.
90. Loewy, A.D. & Spyer, K.M. 1990. Central Regulation of Autonomic Functions, pp. 390. Oxford University Press, New York.
91. Lüdecke, B., Knappskog, M., Clayton, P.T. et al. 1996. Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum Mol Gen 5, 1023-1028.
92. Mannelli, M., Lanzillotti, R., Pupilli, C., Ianni, L., Natali, A. & Bellini, F. 1998. Glucocorticoid-Phenylethanolamine-N-methyltransferase interactions in humans. Adv Pharmacol 42, 69-72.
93. Marletta, M.A., Hurshman, A.R. & Rusche, K.M. 1998. Catalysis by nitric oxide synthase. Curr Opin Chem Biol 2, 656-663.
94. Martinez, A., Haavik, J., Flatmark, T., Arrondo, J.L.R. & Muga, A. 1996. Conformational properties and stability of tyrosine hydroxylase studied by infrared spectroscopy. Effect of iron/catecholamine binding and phosphorylation. J Biol Chem 271, 19737-19742.
95. Maruyama, W. & Naoi, M. 1994. Inhibition of tyrosine hydroxylase by a dopamine neurotoxin, 1-methyl-4-phenylpyridinium ion: depletion of allostery to the biopterin cofactor. Life Sci 55, 207-212.
96. Mefford, I.N. 1987. Are there epinephrine neurons in rat brain? Brain Res 434, 383-395.
97. Mefford, I.N. 1988. Epinephrine in mammalian brain. Prog Neuropsychopharmacol Biol Psychiatry 12, 365-388.
98. Melia, K.R., Rasmussen, K., Terwillinger, R.Z., Haycock, J.W., Nestler, E.J. & Duman, R.S. 1992. Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: effects of chronic stress and drug treatments. J Neurochem 58, 494-502.
99. Milstien, S., Jaffe, H., Kowlessur, D. & Bonner, T.I. 1996. Purification and cloning of the GTP cyclohydrolase I feedback regulatory protein, GFRP. J Biol Chem 271, 19743-19751.
100. Min, N., Joh, T.H., Corp, E.S., Baker, H., Cubells, J.F. & Son, J.H. 1996. A transgenic mouse model to study transsynanptic regulation of tyrosine hydroxylase gene expression. J Neurochem 67, 11-18.
101. Minami, M., Takahashi, T., Maruyama, W., Takahashi, A., Nagatsu, T. & Naoi, M. 1992. Allosteric effect of tetrahydrobiopterin cofactors on tyrosine hydroxylase activity. Life Sci 50, 15-20.
102. Mishra, R.R., Adhikary, G., Simonson, M.S., Cherniack, N.S. & Prabhakar, N.R. 1998. Role of c-fos in hypoxia-induced AP-1 cis-element activity and tyrosine hydroxylase gene expression. Brain Res Mol Brain Res 59, 74-83.
103. Moore, P.S., Dominici, P. & Borri Voltattorni, C. 1996. Cloning and expression of pig kidney dopa decarboxylase: comparison of the naturally occurring and recombinant enzymes. Biochem J 315, 249-256.
104. Morgan, W.W., Walter, C.A., Windle, J.J. & Sharp, Z.D. 1996. 3.6 kb of the 5′ flanking DNA activates the mouse tyrosine hydroxylase gene promoter without catecholaminergic-specific expression. J Neurochem 66, 20-25.
105. Nagatsu, T., Levitt, M. & Udenfriend, S. 1964. Tyrosine hydroxylase: The initial step in norepinephrine biosynthesis. J Biol Chem 239, 2910-2917.
106. Nagatsu, T. 1991. Genes for human catecholamine-synthesizing enzymes. Neurochem Res 12, 315-345.
107. Nankova, B., Kvetnansky, R., Hiremagalur, B., Sabban, B., Rusnak, M. & Sabban, E.L. 1996. Immobilization stress elevates gene expression for catecholamine biosynthetic enzymes and some neuropeptides in rat sympathetic ganglia: effects of adrenocorticotropin and glucocorticoids. Endocrinology 137, 5597-5604.
108. Nankova, B.B., Fuchs, S.Y., Serova, L.I., Ronai, Z., Wild, D. & Sabban, E.L. 1999. Selective in vivo stimulation of stress-activated protein kinase in different rat tissues by immobilization stress. Stress 2, 289-298.
109. - transfer reactions. Biochim Biophys Acta 1144, 235-248.
110. Park, D.H., Wessel, T., Baker, H., Joh, T.H. & Samanta, H. 1991. Characterization of recombinant bovine phenylethanolamine N-methyltransferase expressed in a mouse C127 cell line. Brain Res Mol Brain Res 10, 213-218.
111. Peart, W.S. 1949. The nature of splenic sympathin. J Physiol (Lond) 108, 491-501.
112. Pohorecky, L.A. & Wurtman, R.J. 1971. Adrenocortical control of epinephrine synthesis. Pharmacol Rev 23, 1-35.
113. Quinsey, N.S., Lenaghan, C.M. & Dickson, P.W. 1996. Identification of Gln313 and Pro327 as residues critical for substate inhibition in tyrosine hydroxylase. J Neurochem 66, 908-914.
114. Rebrin, I., Bailey, S.W., Boerth, S.R., Ardell, M.D. & Ayling, J.E. 1995. Catalytic characterization of 4a-hydroxytetrahydropterin dehydratase. Biochemistry 34, 5801-5810.
115. Robertson, D. & Hale, N. 1998. Genetic Diseases of Hypertension. Adv Pharmacol 42, 61-65.
116. Rosano, T.G., Swift, T.A. & Hayes, L.W. 1991. Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma. Clin Chem 37, 1854-1867.
117. Rostrup, M. 1998. Catecholamines, hypoxia and high altitude. Acta Physiol Scand 162, 389-399.
118. Rusnak, M., Zorad, S., Buckendahl, P., Sabban, E.L. & Kvetnansky, R. 1998a. Trosine hydroxylase mRNA levels in locus ceruleus of rats during adaptation to long-term immobilization stress exposure. Mol Chem Neuropathol 33, 249-258.
119. Rusnak, M., Jelokova, J., Vietor, I., Sabban, E.L. & Kvetnansky, R. 1998b. Different effects of insulin and 2-deoxy-d-glucose administration on tyrosine hydroxylase gene expression in the locus coeruleus and the adrenal medulla in rats. Brain Res Bull 46, 447-452.
120. Sabban, E.L. & Nankova, B.B. 1998. Multiple pathways in regulation of dopamine β-hydroxylase. Advan Pharmacol 42, 53-56.
121. Serova, L.I., Nankova, B., Kvetnansky, R. & Sabban, E.L. 1997. Immobilization stress elevates GTP cyclohydrolase 1 mRNA levels in rat adrenals predominantly by hormonally mediated mechanisms. Stress 1, 135-144.
122. Skotland, T. & Flatmark, T. 1979. On the amphiphilic and hydrophilic forms of dopamine β-mono-oxygenase in bovine adrenal medulla. J Neurochem 32, 1861-1863.
123. Skotland, T. & Ljones, T. 1979. Dopamine β-monooxygenase: Structure, mechanism, and properties of the enzyme-bound copper. Inorg Perspect Biol Med 2, 151-180.
124. Stachowiak, M.K., Rigual, R.J., Lee, P.H., Viveros, O.H. & Hong, J.S. 1988. Regulation of tyrosine hydroxylase and phenylethanolamine N-methyltransferase mRNA levels in the sympathoadrenal system by the pituitary-adrenocortical axis. Brain Res 427, 275-286.
125. Stjärne, L. 1999. Catecholaminergic neurotransmission -flagship of all neurobiology. Acta Phys Scand, in press.
126. Sutherland, C., Alterio, J., Camphell, D.G. et al. 1993. Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2. Eur J Biochem 217, 715-722.
127. Takikawa, S., Curtius, H.C., Redweik, U., Leimbacher, W. & Ghisla, S. 1986. Biosynthesis of tetrahydrobiopterin. Purification and characterization of 6-pyruvoultetrahydropterin synthase from human liver. Eur J Biochem 161, 295-302.
128. Taljanidisz, J., Stewart, L., Smith, A.J. & Klinman, J.P. 1989. Structure of bovine adrenal dopamine beta-monooxygenase, as deduced from cDNA and protein sequencing: evidence that the membrane-bound form of the enzyme is anchored by an uncleaved signal peptide. Biochemistry 28, 10054-10061.
129. Tank, A.W., Curella, P. & Ham, L. 1986. Induction of mRNA for tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: evidence for the regulation of tyrosine hydroxylase synthesis by multiple mechanisms in cells exposed to elevated levels of both inducing agents. Mol Pharmacol 30, 497-503.
130. Terland, O. & Flatmark, T. 1975. Ascorbate as a natural constituent of chromaffin granules from the bovine adrenal medulla. FEBS Lett 59, 52-56.
131. Thomas, S.A., Matsumoto, A.M. & Palmiter, R.D. 1995. Noradrenaline is essential for mouse fetal development. Nature 374, 643-646.
132. Thomas, S.A., Marck, B.T., Palmiter, R.D. & Matsumoto, A.M. 1998. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J Neurochem 70, 2468-2476.
133. Thomas, S.A. & Palmiter, R.D. 1998. Examining adrenergic roles in development, physiology, and behaviour through targeted disruption of the mouse dopamine β-hydroxylase gene. Adv Pharmacol 42, 57-60.
134. Trocme, C., Sarkis, C., Hermel, J.M. et al. 1998. CRE and TRE sequences of the rat tyrosine hydroxylase promoter are required for TH basal expression in adult mice but not in the embryo. Eur J Neurosci 10, 508-521.
135. Vogt, M. 1954. The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J Physiol (Lond) 123, 451-481.
136. Vyas, S., Faucon Biguet, N. & Mallet, J. 1990. Transcriptional and post-transcriptional regulation of tyrosine hydroxylase gene by protein kinase C. EMBO J 9, 3707-3912.
137. Weiner, N. 1970. Regulation of norepinephrine biosynthesis. Annu Rev Pharmacol 10, 273-290.
138. Wong, D.L., Siddall, B.J., Ebert, S.N., Bell, R.A. & Her, S. 1998. Phenylethanolamine N-methyltransferase gene expression: synergistic activation by egr-1, AP-2 and the glucocorticoid receptor. Brain Res Mol Brain Res 61, 154-161.
139. Wong, D.L., Yamasaki, L. & Ciaranello, R.D. 1987. Characterization of the isozymes of bovine adrenal medullary phenylethanolamine N-methyltransferase. Brain Res 410, 32-44.
140. Wurtman, R.J. & Axelrod, J. 1965. Adrenalin synthesis: control by the pituitary gland and adrenal glucocorticoids. Science 150, 1464-1465.
141. Yang, S.P., Pau, K.Y. & Spies, H.G. 1997. Gonadectomy alters tyrosine hydroxylase and norepinephrine transporter mRNA levels in the locus coeruleus in rabbits. J Neuroendocrinol 9, 763-768.
142. Yang, H. & Raizada, M.K. 1998. MAP kinase-independent signaling in angiotensin II regulation of neuromodulation in SHR neurons. Hypertension 32, 473-481.
143. Zhou, Q.Y. & Palmiter, R.D. 1995. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83, 1197-1209.